Akebia Therapeutics
AKBA
#7041
Rank
NZ$0.67 B
Marketcap
$3.12
Share price
1.68%
Change (1 day)
90.51%
Change (1 year)

Market capitalization of Akebia Therapeutics (AKBA)

Market cap: NZ$0.67 Billion

As of November 2024 Akebia Therapeutics has a market cap of NZ$0.67 Billion. This makes Akebia Therapeutics the world's 7041th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Akebia Therapeutics from 2014 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$0.67 B84.01%
2023NZ$0.36 B120.95%
2022NZ$0.16 B-71.12%
2021NZ$0.57 B3.21%
2020NZ$0.56 B-50.88%
2019NZ$1.14 B18.49%
2018NZ$0.96 B-2.63%
2017NZ$0.98 B71.84%
2016NZ$0.57 B-0.5%
2015NZ$0.57 B91.27%
2014NZ$0.30 B

End of Day market cap according to different sources

On Nov 21st, 2024 the market cap of Akebia Therapeutics was reported to be:

NZ$0.67 Billion
by Nasdaq info icon info icon
NZ$0.67 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$266.73 B 39,143.26%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$355.39 B 52,186.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$640.83 B 94,182.27%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.31 B-53.08%๐Ÿ‡บ๐Ÿ‡ธ USA